179 related articles for article (PubMed ID: 35173309)
1. LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer.
Wu H; Ding X; Hu X; Zhao Q; Chen Q; Sun T; Li Y; Guo H; Li M; Gao Z; Yao W; Zhao L; Li K; Wei M
Oncogene; 2022 Mar; 41(13):1959-1973. PubMed ID: 35173309
[TBL] [Abstract][Full Text] [Related]
2. N6-methyladenosine reader IMP2 stabilizes the ZFAS1/OLA1 axis and activates the Warburg effect: implication in colorectal cancer.
Lu S; Han L; Hu X; Sun T; Xu D; Li Y; Chen Q; Yao W; He M; Wang Z; Wu H; Wei M
J Hematol Oncol; 2021 Nov; 14(1):188. PubMed ID: 34743750
[TBL] [Abstract][Full Text] [Related]
3. METTL3 facilitates tumor progression via an m
Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
[TBL] [Abstract][Full Text] [Related]
4. LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification.
Hou P; Meng S; Li M; Lin T; Chu S; Li Z; Zheng J; Gu Y; Bai J
J Exp Clin Cancer Res; 2021 Feb; 40(1):52. PubMed ID: 33526059
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m
Ni W; Yao S; Zhou Y; Liu Y; Huang P; Zhou A; Liu J; Che L; Li J
Mol Cancer; 2019 Oct; 18(1):143. PubMed ID: 31619268
[TBL] [Abstract][Full Text] [Related]
6. N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal Cancer.
Wang S; Gao S; Zeng Y; Zhu L; Mo Y; Wong CC; Bao Y; Su P; Zhai J; Wang L; Soares F; Xu X; Chen H; Hezaveh K; Ci X; He A; McGaha T; O'Brien C; Rottapel R; Kang W; Wu J; Zheng G; Cai Z; Yu J; He HH
Gastroenterology; 2022 Apr; 162(4):1183-1196. PubMed ID: 34968454
[TBL] [Abstract][Full Text] [Related]
7. m
Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer.
Wang Y; Lu JH; Wu QN; Jin Y; Wang DS; Chen YX; Liu J; Luo XJ; Meng Q; Pu HY; Wang YN; Hu PS; Liu ZX; Zeng ZL; Zhao Q; Deng R; Zhu XF; Ju HQ; Xu RH
Mol Cancer; 2019 Dec; 18(1):174. PubMed ID: 31791342
[TBL] [Abstract][Full Text] [Related]
9. EGR2-mediated regulation of m
Ying Y; Ma X; Fang J; Chen S; Wang W; Li J; Xie H; Wu J; Xie B; Liu B; Wang X; Zheng X; Xie L
Cell Death Dis; 2021 Jul; 12(8):750. PubMed ID: 34326314
[TBL] [Abstract][Full Text] [Related]
10. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
[TBL] [Abstract][Full Text] [Related]
11. An oncopeptide regulates m
Zhu S; Wang JZ; Chen D; He YT; Meng N; Chen M; Lu RX; Chen XH; Zhang XL; Yan GR
Nat Commun; 2020 Apr; 11(1):1685. PubMed ID: 32245947
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor 2 mRNA-binding protein 2-stabilized long non-coding RNA Taurine up-regulated gene 1 (TUG1) promotes cisplatin-resistance of colorectal cancer via modulating autophagy.
Xia C; Li Q; Cheng X; Wu T; Gao P; Gu Y
Bioengineered; 2022 Feb; 13(2):2450-2469. PubMed ID: 35014946
[TBL] [Abstract][Full Text] [Related]
13. N
Zhang Z; Xing Y; Gao W; Yang L; Shi J; Song W; Li T
Bioengineered; 2022 May; 13(5):11541-11550. PubMed ID: 35502827
[TBL] [Abstract][Full Text] [Related]
14. The m
Bechara R; Amatya N; Bailey RD; Li Y; Aggor FEY; Li DD; Jawale CV; Coleman BM; Dai N; Gokhale NS; Taylor TC; Horner SM; Poholek AC; Bansal A; Biswas PS; Gaffen SL
Sci Immunol; 2021 Jul; 6(61):. PubMed ID: 34215679
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression.
Zhong X; Lü M; Wan J; Zhou T; Qin B
Biomed Pharmacother; 2018 Nov; 107():382-389. PubMed ID: 30099342
[TBL] [Abstract][Full Text] [Related]
16. N
Li Y; He L; Wang Y; Tan Y; Zhang F
Bioengineered; 2022 May; 13(5):11923-11932. PubMed ID: 35546050
[TBL] [Abstract][Full Text] [Related]
17. LCAT1 is an oncogenic LncRNA by stabilizing the IGF2BP2-CDC6 axis.
Yang J; Qian X; Qiu Q; Xu L; Pan M; Li J; Ren J; Lu B; Qiu T; Chen E; Ying K; Zhang H; Lu Y; Liu P
Cell Death Dis; 2022 Oct; 13(10):877. PubMed ID: 36257938
[TBL] [Abstract][Full Text] [Related]
18. m
Wu Y; Yang X; Chen Z; Tian L; Jiang G; Chen F; Li J; An P; Lu L; Luo N; Du J; Shan H; Liu H; Wang H
Mol Cancer; 2019 Apr; 18(1):87. PubMed ID: 30979372
[TBL] [Abstract][Full Text] [Related]
19. RNA m6A reader IMP2/IGF2BP2 promotes pancreatic β-cell proliferation and insulin secretion by enhancing PDX1 expression.
Regué L; Zhao L; Ji F; Wang H; Avruch J; Dai N
Mol Metab; 2021 Jun; 48():101209. PubMed ID: 33705986
[TBL] [Abstract][Full Text] [Related]
20. Super-enhancer-associated long noncoding RNA RP11-569A11.1 inhibited cell progression and metastasis by regulating IFIT2 in colorectal cancer.
Chen H; Zheng J; Yan L; Zhou X; Jiang P; Yan F
J Clin Lab Anal; 2021 Jun; 35(6):e23780. PubMed ID: 33942366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
